Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||UNKNOWN / 2||LA / -|
Administered by: Pharmacy Purchased by: ??
Symptoms: Anxiety, Dizziness, Headache, Lymphadenopathy, Nausea, Pain, Pyrexia, SARS-CoV-2 test
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Other Medications: BENADRYL; IBUPROFEN; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VITAMIN D [COLECALCIFEROL]
Preexisting Conditions: Medical History/Concurrent Conditions: Anxiety; Fibromyalgia; Postural orthostatic tachycardia syndrome
Diagnostic Lab Data: Test Date: 202109; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Unknown results
CDC 'Split Type': USPFIZER INC202101167626
Write-up: Severe headache; fever; body aches; severe anxiety; nausea; dizziness; swollen glands; This is a spontaneous report received from a contactable consumer(patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number was unknown and expiry date was not reported) via an unspecified route of administration, on 04Sep2021 13:00, at the Left arm, at the age of 38-year-old, at dose 2, single for covid-19 immunisation in a pharmacy or drug store. The patient''s medical history includes fibromyalgia, postural orthostatic tachycardia syndrome, and anxiety. Concomitant medications in two weeks include diphenhydramine hydrochloride (BENADRYL), ibuprofen, cetirizine hydrochloride (ZYRTEC), colecalciferol (VITAMIN D), and multivitamin (unspecified). The patient previously took cymbalta, phenergan and oxycodone hydrochloride, paracetamol (PERCOCET) and experienced allergies. The patient did not receive other vaccines in two weeks. The patient is not pregnant at the time of vaccination. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiry date were not reported) via an unspecified route of administration, on 14Aug2021 12:30 at the right arm, at dose 1, single, for covid-19 immunisation. The patient did not have prior COVID vaccination. On 07Sep2021, the patient experienced severe headache, fever, body aches, severe anxiety, nausea, dizziness, swollen gland resulted in Emergency room/department or urgent care. The patient underwent nasal swab post vaccination in Sep2021 but the result was unknown. The patient received treatment in response to the events which included fluids, anti-nausea medication, pain reliever. The outcome of the events was not recovered. The lot number for BNT162B2, was not provided and will be requested during follow up.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166